Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: A retrospective study-Reference-Cited by-同舟云学术

Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: A retrospective study

Published:2024-02-22 Issue:4 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Higashi Toshiya¹,Murase Katsutoshi¹,Watanabe Daichi²,Ishihara Takuma³,Yokoi Ryoma¹,Kuno Masashi¹,Fukada Masahiro¹,Iwashita Takuji⁴,Tajima Jesse¹,Kiyama Shigeru¹,Tanaka Yoshihiro¹,Okumura Naoki¹,Shimizu Masahito⁴,Matsuhashi Nobuhisa¹

Affiliation:

1. Department of Gastroenterological Surgery, Gifu University Hospital, Gifu 501‑1194 Japan

2. Department of Pharmacy, Gifu University Hospital, Gifu 501‑1194 Japan

3. Department of Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu 501‑1194 Japan

4. First Department of Internal Medicine, Gifu University Hospital, Gifu 501‑1194 Japan

Publisher

Spandidos Publications

Reference36 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Pancreatic cancer;Vincent;Lancet,2011

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

5. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: Results of a project study for pancreatic surgery by the Japanese society of hepato-biliary-pancreatic surgery;Satoi;J Hepatobiliary Pancreat Sci,2013